|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
97.27(B) |
Last
Volume: |
7,659,790 |
Avg
Vol: |
8,465,245 |
52
Week Range: |
$48.64 - $68.84 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
Total People Sold |
6 |
8 |
11 |
13 |
Total Sell Transactions |
9 |
19 |
36 |
69 |
End Date |
2024-01-21 |
2023-10-20 |
2023-04-21 |
2022-04-21 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Phalen Michael P. |
EVP & President, MedSurg |
|
2014-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
62,471 |
146,771 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2014-02-24 |
4 |
D |
$13.08 |
$103,685 |
D/D |
(7,927) |
87,818 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2014-02-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,612 |
95,745 |
|
- |
|
Brennan Daniel J. |
EVP and CFO |
|
2014-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
20,823 |
92,133 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2014-02-21 |
4 |
S |
$13.19 |
$105,530 |
D/D |
(8,000) |
58,600 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2014-02-21 |
4 |
S |
$13.19 |
$403,523 |
D/D |
(30,588) |
22,626 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2014-02-21 |
4 |
AS |
$13.22 |
$42,275 |
D/D |
(3,199) |
25,600 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2014-02-21 |
4 |
AS |
$13.22 |
$42,579 |
D/D |
(3,222) |
84,300 |
|
- |
|
Nicholas Nicholas J Jr |
Director |
|
2014-02-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,700 |
1,900 |
|
- |
|
Pucel Kenneth |
EVP, Glob Ops, Qual & Tech |
|
2014-02-19 |
4 |
S |
$13.32 |
$1,038,820 |
D/D |
(78,000) |
59,000 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2014-02-18 |
4 |
AS |
$13.30 |
$179,550 |
D/D |
(13,500) |
87,522 |
|
- |
|
Phalen Michael P. |
EVP & President, MedSurg |
|
2014-02-18 |
4 |
OE |
$7.41 |
$104,040 |
D/D |
13,500 |
101,022 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2014-02-16 |
4 |
D |
$13.30 |
$20,123 |
D/D |
(1,513) |
22,004 |
|
- |
|
Carruthers Wendy |
SVP, Human Resources |
|
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,359 |
23,517 |
|
- |
|
Onuscheck John Michael |
SVP & President, Europe |
|
2014-02-16 |
4 |
D |
$13.30 |
$37,732 |
D/D |
(2,837) |
76,016 |
|
- |
|
Onuscheck John Michael |
SVP & President, Europe |
|
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,060 |
78,853 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2014-02-16 |
4 |
D |
$13.30 |
$54,011 |
D/D |
(4,061) |
66,600 |
|
- |
|
Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
|
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,471 |
70,661 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2014-02-16 |
4 |
D |
$13.30 |
$25,563 |
D/D |
(1,922) |
28,799 |
|
- |
|
Pierce David A |
SVP and President, Endoscopy |
|
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,121 |
30,721 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2014-02-16 |
4 |
D |
$13.30 |
$23,860 |
D/D |
(1,794) |
86,884 |
|
- |
|
Fitzgerald Joseph Michael |
SVP & President, CRM |
|
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,723 |
88,678 |
|
- |
|
Pucel Kenneth |
EVP, Glob Ops, Qual & Tech |
|
2014-02-16 |
4 |
D |
$13.30 |
$31,667 |
D/D |
(2,381) |
137,000 |
|
- |
|
Pucel Kenneth |
EVP, Glob Ops, Qual & Tech |
|
2014-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,747 |
139,381 |
|
- |
|
Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
|
2014-02-16 |
4 |
D |
$13.30 |
$53,666 |
D/D |
(4,035) |
53,214 |
|
- |
|
1824 Records found
|
|
Page 6 of 73 |
|
|